• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting.

作者信息

Wilson Stephanie H, Fasseas Panayotis, Orford James L, Lennon Ryan J, Horlocker Terese, Charnoff Nina E, Melby Steven, Berger Peter B

机构信息

Department of Cardiology, St. Vincent's Hospital, Darlinghurst, Australia.

出版信息

J Am Coll Cardiol. 2003 Jul 16;42(2):234-40. doi: 10.1016/s0735-1097(03)00622-3.

DOI:10.1016/s0735-1097(03)00622-3
PMID:12875757
Abstract

OBJECTIVES

We sought to determine the frequency and timing of complications at our institution when surgery was performed within two months of coronary stent placement.

BACKGROUND

The optimal delay following coronary stent placement prior to non-cardiac surgery is unknown.

METHODS

We analyzed the Mayo Clinic Percutaneous Coronary Intervention and Surgical databases between 1990 and 2000 and identified 207 patients who underwent surgery in the two months following successful coronary stent placement.

RESULTS

Eight patients (4.0%) died or suffered a myocardial infarction or stent thrombosis. All 8 patients were among the 168 patients (4.8%, 95% confidence interval [CI] 2.1 to 9.2) undergoing surgery six weeks after stent placement; the frequency of these events ranged from 3.8% to 7.1% per week during each of the six weeks. No events occurred in the 39 patients undergoing surgery seven to nine weeks after stent placement (0%, 95% CI 0.0 to 9.0).

CONCLUSIONS

These data suggest that, whenever possible, non-cardiac surgery should be delayed six weeks after stent placement, by which time stents are generally endothelialized, and a course of antiplatelet therapy to prevent stent thrombosis has been completed.

摘要

相似文献

1
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting.
J Am Coll Cardiol. 2003 Jul 16;42(2):234-40. doi: 10.1016/s0735-1097(03)00622-3.
2
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.当代冠状动脉支架血栓形成的发生率及相关因素:一项单中心注册研究分析
J Am Coll Cardiol. 2002 Nov 6;40(9):1567-72. doi: 10.1016/s0735-1097(02)02374-4.
3
Catastrophic outcomes of noncardiac surgery soon after coronary stenting.
J Am Coll Cardiol. 2000 Apr;35(5):1288-94. doi: 10.1016/s0735-1097(00)00521-0.
4
Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.冠状动脉支架置入术后单纯抗血小板治疗安全有效:实践转变观察
Can J Cardiol. 1997 Apr;13(4):335-40.
5
Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.用于治疗冠状动脉慢性完全闭塞病变的维克托支架:来自大型多中心研究的短期和长期临床及血管造影结果
J Am Coll Cardiol. 1998 Feb;31(2):281-8. doi: 10.1016/s0735-1097(97)00490-7.
6
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.阿司匹林、氯吡格雷和华法林在有抗凝指征的冠心病支架置入术后患者中的安全性和有效性。
Am Heart J. 2004 Mar;147(3):463-7. doi: 10.1016/j.ahj.2003.06.004.
7
The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery.在植入药物洗脱支架至少 6 个月后接受非心脏手术的患者中,手术后发生心脏并发症的风险。
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):837-43. doi: 10.1002/ccd.22158.
8
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.在血管内超声引导下进行无抗凝治疗的冠状动脉内支架置入术。
Circulation. 1995 Mar 15;91(6):1676-88. doi: 10.1161/01.cir.91.6.1676.
9
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.急性心肌梗死后经皮冠状动脉介入治疗后支架血栓形成的频率及预测因素。
Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11.
10
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.药物洗脱支架置入术后 1 年内再次行非心脏大手术及随后发生不良事件的频率:来自 EVENT(药物洗脱支架和缺血事件评估)注册研究的结果。
JACC Cardiovasc Interv. 2010 Sep;3(9):920-7. doi: 10.1016/j.jcin.2010.03.021.

引用本文的文献

1
Frequent Gastrointestinal Cancer Complications in Japanese Patients with Acute or Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的日本急性或慢性冠状动脉综合征患者中频繁出现的胃肠道癌症并发症
J Clin Med. 2025 Mar 7;14(6):1807. doi: 10.3390/jcm14061807.
2
Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial.围手术期低分子量肝素治疗对既往冠状动脉支架植入超过12个月的老年患者行非心脏手术临床事件的影响:一项随机、安慰剂对照试验。
BMC Med. 2024 Apr 23;22(1):171. doi: 10.1186/s12916-024-03391-2.
3
Comparison of Early and Late Surgeries after Coronary Stent Implantation in Patients with Normal Preoperative Troponin Level: A Retrospective Study.
术前肌钙蛋白水平正常的冠心病支架植入患者早期与晚期手术的比较:一项回顾性研究
J Clin Med. 2023 Mar 27;12(7):2524. doi: 10.3390/jcm12072524.
4
Update of the Brazilian Society of Cardiology's Perioperative Cardiovascular Assessment Guideline: Focus on Managing Patients with Percutaneous Coronary Intervention - 2022.巴西心脏病学会围手术期心血管评估指南更新:聚焦经皮冠状动脉介入治疗患者的管理 - 2022年
Arq Bras Cardiol. 2022 Feb;118(2):536-547. doi: 10.36660/abc.20220039.
5
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.冠心病患者的非心脏手术:风险评估和围手术期管理。
Nat Rev Cardiol. 2021 Jan;18(1):37-57. doi: 10.1038/s41569-020-0410-z. Epub 2020 Aug 5.
6
Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence.阿司匹林预防肾移植心血管事件的利弊及证据综述
Adv Prev Med. 2019 May 16;2019:6139253. doi: 10.1155/2019/6139253. eCollection 2019.
7
Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery.骨科手术中继续双联抗血小板治疗患者的出血风险。
Chin Med J (Engl). 2019 Apr 20;132(8):943-947. doi: 10.1097/CM9.0000000000000186.
8
Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review.经皮冠状动脉支架置入术后非心脏手术患者抗血小板治疗的围手术期管理:系统评价。
Syst Rev. 2018 Jan 10;7(1):4. doi: 10.1186/s13643-017-0635-z.
9
Mortality Risk Assessment of Total Knee Arthroplasty and Related Surgery After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后全膝关节置换术及相关手术的死亡风险评估
Open Orthop J. 2016 Dec 21;10:706-716. doi: 10.2174/1874325001610010706. eCollection 2016.
10
The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection.潜在心脏合并症对肝大部切除术后主要不良心脏事件的影响
HPB (Oxford). 2016 Sep;18(9):742-7. doi: 10.1016/j.hpb.2016.06.012. Epub 2016 Jul 21.